✦ LIBER ✦

Induced Pluripotent Stem Cells and Human Disease

✍ Scribed by Alan Colman

Book ID: 116891094
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 3
Category: Article
ISSN: 1934-5909
DOI: 10.1016/j.stem.2008.08.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epigenomics of human embryonic stem cell

Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease

✍ Alvaro Rada-Iglesias; Joanna Wysocka 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 957 KB

Alzheimer's Disease Modeling: Ups, Downs

Alzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells

✍ Wojda, Urszula ;Kuznicki, Jacek 📂 Article 📅 2013 🏛 IOS Press 🌐 English ⚖ 399 KB

Human Pompe disease-induced pluripotent

Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification

✍ Huang, H.-P.; Chen, P.-H.; Hwu, W.-L.; Chuang, C.-Y.; Chien, Y.-H.; Stone, L.; C 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 893 KB

Human induced pluripotent stem cells der

Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy

✍ Fei Yi, Guang-Hui Liu, Juan Carlos Izpisua Belmonte 📂 Article 📅 2012 🏛 SP Higher Education Press 🌐 English ⚖ 192 KB

Deciphering the complexities of human di

Deciphering the complexities of human diseases and disorders by coupling induced-pluripotent stem cells and systems genetics

✍ Wing Y. Chang; Kamal Garcha; Janet L. Manias; William L. Stanford 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 347 KB

Modeling and therapy of human liver dise

Modeling and therapy of human liver diseases using induced pluripotent stem cells: How far have we come?

✍ Alejandro Soto-Gutierrez; Edgar Tafaleng; Victoria Kelly; Jayanta Roy-Chowdhury; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

End-stage liver disease caused by chronic hepatitis C virus (HCV) infection is a leading cause for liver transplantation (LT). Due to viral evasion from host immune responses and the absence of preventive antiviral strategies, reinfection of the graft is universal. The mechanisms by which the virus